Children's Hospital of Wisconsin, INC.

Children's Hospital of Wisconsin, INC. was paid $262.20M by Medicaid between Jan 2018 and Dec 2024, across 781 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 15% of everything it billed.

33Billing provider infoCHILDREN'S HOSPITAL OF WISCONSIN, INC.
MILWAUKEE, WI 53226

33aNPI1750482022assigned 09/26/2006

33bProvider typePediatric Dentist

28Total paid$262.20M

24GClaims4,551,447

24DCodes billed781

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Pediatric Dentist providers in Wisconsin

Rank by total paid#1 of 61

Median peer was paid$85K

This provider vs. median3,086×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	596,883	$39.79M
2019	636,787	$40.57M
2020	504,022	$29.49M
2021	658,308	$34.13M
2022	680,457	$36.01M
2023	740,638	$42.03M
2024incomplete	734,352	$40.18M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	15%	355,637	314,455	$38.41M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	7.0%	180,908	165,764	$18.27M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	5.7%	143,014	126,499	$14.91M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	4.2%	100,861	92,492	$10.92M
99282	Emergency department visit for the evaluation and management, low to moderate severity	3.2%	85,830	80,332	$8.47M
80053	Comprehensive metabolic panel	2.2%	65,160	51,972	$5.75M
D0120	Dental checkup, returning patientPeriodic oral evaluation - established patient	2.1%	59,735	56,417	$5.60M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	2.1%	38,930	33,872	$5.41M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	1.7%	43,169	39,573	$4.39M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.7%	80,499	38,264	$4.35M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	1.4%	23,508	22,245	$3.62M
P9016	Red blood cells, leukocytes reduced, each unit	1.3%	4,930	4,066	$3.40M

769 more codes

99215	Doctor's office visit, returning patient (complex)	1.3%	37,851	$3.40M
41899	Unlisted procedure, dentoalveolar structures	1.3%	5,074	$3.29M
42820	Tonsillectomy and adenoidectomy; younger than age 12	1.2%	4,113	$3.08M
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	1.1%	65,316	$2.79M
D2930	Prefabricated stainless steel crown - primary tooth	1.1%	19,264	$2.77M
G0378	Hospital observation service, per hour	<1%	15,551	$2.60M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	19,144	$2.58M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	10,700	$2.38M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	36,292	$2.37M
92567		<1%	36,231	$1.98M
96361	Intravenous infusion, hydration; each additional hour	<1%	10,224	$1.97M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	25,551	$1.88M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	2,141	$1.86M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	5,721	$1.84M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	11,189	$1.78M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	20,091	$1.69M
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	33,887	$1.67M
D1120	Dental cleaning, child	<1%	51,472	$1.65M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	3,381	$1.62M
93320		<1%	10,789	$1.59M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	88,941	$1.52M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	29,172	$1.39M
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	6,851	$1.37M
D1206	Topical application of fluoride varnish	<1%	67,166	$1.28M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	3,861	$1.22M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	5,044	$1.17M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	1,490	$1.15M
93325		<1%	17,754	$1.13M
80048	Basic metabolic panel (calcium, ionized)	<1%	15,370	$1.11M
70450	Computed tomography, head or brain; without contrast material	<1%	6,643	$1.08M
36430		<1%	5,154	$1.07M
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	16,889	$1.05M
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	12,633	$1.04M
D8670	Periodic orthodontic treatment visit	<1%	4,969	$1.04M
96040		<1%	8,142	$1.01M
90834	Psychotherapy session, about 45 minutes	<1%	10,321	$983K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	4,988	$962K
D7140	Extraction, erupted tooth or exposed root	<1%	7,526	$955K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	20,894	$920K
64643		<1%	3,226	$909K
95782		<1%	2,632	$888K
81229		<1%	1,582	$887K
76775		<1%	10,431	$873K
86900		<1%	9,123	$866K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	4,057	$860K
93321		<1%	5,501	$860K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	6,530	$857K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	4,542	$843K
D1351	Sealant - per tooth	<1%	20,752	$837K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	3,919	$819K
92579		<1%	16,267	$817K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	16,568	$795K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	6,722	$776K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	13,064	$756K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	6,326	$751K
87070		<1%	13,524	$749K
93308		<1%	3,594	$746K
86003		<1%	49,661	$738K
82728		<1%	26,582	$722K
93356		<1%	3,995	$685K
D9920		<1%	3,272	$671K
83036	Hemoglobin; glycosylated (A1C)	<1%	28,359	$668K
42830		<1%	968	$668K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	16,770	$630K
D0150	Comprehensive oral evaluation - new or established patient	<1%	4,996	$625K
84443	Thyroid stimulating hormone (TSH)	<1%	31,186	$610K
80061	Lipid panel	<1%	17,897	$608K
11900		<1%	5,195	$606K
82803		<1%	8,155	$596K
96367		<1%	5,211	$586K
92587		<1%	9,279	$564K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	5,472	$553K
84439		<1%	18,957	$552K
95819		<1%	3,410	$546K
92523		<1%	5,604	$540K
64642		<1%	3,704	$518K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	2,975	$498K
81003		<1%	23,638	$491K
D1110	Prophylaxis - adult	<1%	12,924	$491K
81025		<1%	18,176	$468K
44970		<1%	318	$466K
93304		<1%	2,032	$454K
D0272	Bitewings - two radiographic images	<1%	30,647	$451K
80197		<1%	9,770	$447K
83021		<1%	7,737	$445K
87077		<1%	25,693	$443K
17110		<1%	4,249	$430K
99285	Emergency room visit (most serious)	<1%	4,351	$426K
71046	Radiologic examination, chest; 2 views	<1%	27,215	$423K
29075		<1%	4,737	$406K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	4,661	$404K
94010		<1%	22,798	$396K
92555		<1%	8,006	$389K
82247		<1%	9,527	$373K
97162		<1%	6,464	$373K
93976		<1%	5,761	$369K
96910		<1%	4,445	$366K
96415		<1%	2,055	$365K
87086	Culture, bacterial; quantitative colony count, urine	<1%	22,331	$362K
97161		<1%	6,080	$353K
82962		<1%	15,129	$352K
95700		<1%	2,224	$350K
92557		<1%	3,090	$345K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	4,265	$344K
95874		<1%	3,076	$344K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	2,260	$344K
12011		<1%	3,085	$339K
83655		<1%	10,611	$335K
92504		<1%	9,787	$320K
92610		<1%	5,005	$313K
95816		<1%	1,688	$310K
97116		<1%	10,382	$302K
95117		<1%	6,147	$295K
29065		<1%	3,214	$292K
74018		<1%	11,819	$291K
87799		<1%	6,708	$290K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	989	$289K
85027		<1%	31,949	$288K
99170		<1%	1,923	$287K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,895	$287K
93225		<1%	2,878	$284K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	10,475	$284K
92588		<1%	6,686	$282K
82657		<1%	5,932	$280K
20670		<1%	475	$279K
92552		<1%	5,181	$277K
29405		<1%	4,180	$276K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,369	$272K
92526		<1%	5,602	$270K
85007		<1%	15,763	$270K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	12,888	$267K
82784		<1%	14,997	$264K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	6,522	$259K
D9230	Inhalation of nitrous oxide / analgesia, anxiolysis	<1%	7,960	$254K
81001		<1%	22,927	$254K
92582		<1%	7,359	$251K
74230		<1%	1,616	$250K
70543		<1%	929	$248K
72141		<1%	1,819	$247K
12001		<1%	2,039	$238K
85610		<1%	14,573	$233K
49452		<1%	716	$228K
96450		<1%	1,374	$227K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	3,513	$226K
84450		<1%	15,967	$222K
D0140	Limited oral evaluation - problem focused	<1%	1,429	$220K
31575		<1%	2,173	$216K
86140		<1%	18,081	$211K
80164		<1%	2,959	$207K
86832		<1%	1,593	$204K
83880		<1%	5,069	$203K
92556		<1%	4,456	$201K
81415		<1%	245	$201K
87506		<1%	986	$200K
94644		<1%	7,116	$200K
90686		<1%	18,104	$199K
31622		<1%	325	$195K
24538		<1%	103	$195K
87497		<1%	4,553	$191K
76536		<1%	2,609	$188K
V5020	Conformity evaluation	<1%	1,741	$187K
86833		<1%	1,594	$185K
D0330	Panoramic radiographic image	<1%	3,321	$182K
82330		<1%	4,878	$181K
72082		<1%	7,240	$178K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,788	$175K
D0220	Intraoral - periapical first radiographic image	<1%	10,854	$174K
87088		<1%	7,166	$174K
97535	Self-care/home management training, each 15 minutes	<1%	8,250	$170K
76885		<1%	1,898	$167K
43762		<1%	3,068	$166K
85576		<1%	2,776	$166K
89051		<1%	2,313	$166K
97166		<1%	2,970	$165K
86920		<1%	8,969	$164K
70486		<1%	1,717	$159K
72146		<1%	1,554	$159K
74240		<1%	1,852	$154K
96156		<1%	2,724	$151K
80051		<1%	2,263	$151K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	19,751	$150K
92611		<1%	1,414	$149K
G0379	Direct admission of patient for hospital observation care	<1%	2,670	$147K
87507		<1%	417	$147K
D0240		<1%	12,849	$146K
76870		<1%	2,102	$146K
95951		<1%	766	$146K
81479	Unlisted molecular pathology procedure	<1%	2,090	$145K
83986		<1%	1,846	$145K
73610		<1%	9,698	$140K
82565		<1%	7,851	$138K
73630		<1%	10,849	$137K
87186		<1%	14,458	$133K
85397		<1%	4,175	$130K
83970		<1%	3,077	$130K
92015	Determination of refractive state	<1%	33,283	$127K
95712		<1%	936	$127K
96136		<1%	1,108	$121K
97165		<1%	2,137	$120K
86902		<1%	7,495	$120K
84460		<1%	19,425	$119K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	1,971	$118K
85246		<1%	4,057	$116K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	4,194	$116K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	3,640	$115K
92553		<1%	1,488	$114K
92585		<1%	981	$114K
83735		<1%	15,223	$113K
83550		<1%	12,008	$113K
16020		<1%	1,780	$109K
82397		<1%	2,508	$108K
J2545	Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg	<1%	752	$106K
95715		<1%	451	$105K
90792	Psychiatric diagnostic evaluation with medical services	<1%	733	$104K
10060		<1%	1,121	$103K
72170		<1%	6,994	$101K
24640		<1%	483	$101K
83540		<1%	12,335	$100K
73140		<1%	6,663	$100K
87040		<1%	6,187	$99K
76770		<1%	968	$99K
82785		<1%	2,382	$96K
82150		<1%	3,580	$95K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	15,980	$95K
83520		<1%	2,551	$94K
85045		<1%	20,097	$93K
94660		<1%	329	$93K
96158		<1%	3,903	$93K
29345		<1%	897	$93K
96132		<1%	1,183	$92K
82570		<1%	6,847	$92K
96112		<1%	2,151	$91K
82043		<1%	2,895	$91K
83002		<1%	2,853	$91K
92586		<1%	630	$89K
86592		<1%	3,488	$88K
94645		<1%	3,929	$88K
84403		<1%	3,192	$87K
87529		<1%	2,234	$85K
83516		<1%	6,053	$84K
84100		<1%	15,941	$81K
92524		<1%	1,864	$81K
80076		<1%	2,228	$81K
76000		<1%	4,566	$80K
D0274	Bitewings - four radiographic images	<1%	4,662	$78K
77072		<1%	3,150	$77K
80195		<1%	1,874	$77K
80177		<1%	486	$76K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	251	$75K
82310		<1%	1,777	$75K
86481		<1%	839	$74K
25605		<1%	344	$73K
83690		<1%	6,970	$73K
83615		<1%	8,445	$72K
83993		<1%	1,368	$71K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	2,979	$71K
92593		<1%	1,158	$70K
84305		<1%	2,697	$69K
73110		<1%	3,888	$68K
73090		<1%	8,888	$68K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	10,635	$67K
96137		<1%	523	$67K
96133		<1%	955	$67K
73590		<1%	8,052	$67K
96139		<1%	1,030	$66K
96138		<1%	1,085	$65K
74183		<1%	321	$65K
87101		<1%	2,726	$65K
73130		<1%	5,868	$64K
73552		<1%	4,516	$63K
92060		<1%	15,259	$63K
12051		<1%	480	$62K
D1354		<1%	2,674	$62K
82139		<1%	726	$61K
82947		<1%	7,546	$61K
70360		<1%	4,036	$61K
75561		<1%	330	$61K
83001		<1%	2,653	$61K
76377		<1%	1,409	$60K
49465		<1%	204	$60K
85730		<1%	8,890	$60K
D2393	Resin-based composite - three surfaces, posterior, primary or permanent	<1%	714	$59K
82550		<1%	4,405	$59K
77080		<1%	945	$58K
85652		<1%	17,460	$58K
73560		<1%	6,435	$58K
96152		<1%	1,400	$57K
82105		<1%	1,756	$57K
72156		<1%	280	$56K
88185		<1%	3,864	$54K
76881		<1%	707	$54K
87205		<1%	12,949	$54K
75565		<1%	632	$54K
82670		<1%	1,466	$53K
86803		<1%	3,101	$52K
82977		<1%	6,286	$52K
87081		<1%	3,577	$52K
76882		<1%	1,084	$52K
73070		<1%	8,015	$51K
72158		<1%	269	$51K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	39,311	$50K
76825		<1%	1,224	$50K
80143		<1%	2,185	$50K
51600		<1%	706	$50K
86850		<1%	8,538	$49K
86160		<1%	3,587	$49K
82040		<1%	1,681	$49K
83498		<1%	1,700	$48K
86364		<1%	4,723	$48K
82248		<1%	5,511	$48K
99157		<1%	9,908	$48K
87210		<1%	2,455	$48K
86945		<1%	7,463	$48K
96376		<1%	5,231	$47K
82607		<1%	2,040	$47K
93226		<1%	2,889	$47K
96375	Therapeutic injection; each additional sequential IV push	<1%	10,971	$47K
72157		<1%	245	$47K
72081		<1%	6,687	$46K
94642		<1%	718	$46K
86376		<1%	2,938	$45K
97163		<1%	807	$44K
84145		<1%	1,125	$44K
82533		<1%	1,512	$44K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,196	$44K
43760		<1%	356	$44K
74019		<1%	4,475	$43K
84484		<1%	3,260	$43K
85240		<1%	2,802	$43K
J2997	Injection, alteplase recombinant, 1 mg	<1%	505	$43K
29105		<1%	1,211	$42K
29450		<1%	294	$42K
94060		<1%	2,668	$41K
70544		<1%	164	$41K
69210		<1%	2,597	$40K
96130		<1%	291	$40K
90791	Psychiatric diagnostic evaluation	<1%	695	$40K
77076		<1%	1,236	$39K
84402		<1%	1,443	$39K
73562		<1%	1,904	$38K
92652		<1%	1,139	$38K
97803		<1%	13,056	$38K
80299		<1%	602	$37K
0001A		<1%	1,302	$37K
96116		<1%	524	$36K
82627		<1%	1,141	$36K
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	830	$36K
D9420		<1%	350	$35K
87631		<1%	267	$35K
51701		<1%	6,073	$35K
51741		<1%	416	$35K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	520	$35K
86038		<1%	2,522	$35K
82017		<1%	531	$35K
92592		<1%	537	$35K
81002		<1%	1,457	$34K
92595		<1%	329	$34K
90832	Psychotherapy session, about 30 minutes	<1%	661	$34K
86706		<1%	2,684	$33K
90656		<1%	3,261	$32K
74455		<1%	465	$32K
J2515	Injection, pentobarbital sodium, per 50 mg	<1%	1,105	$32K
87185		<1%	360	$32K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	271	$32K
84295		<1%	3,273	$31K
49446		<1%	78	$31K
29125		<1%	1,007	$31K
20680		<1%	35	$31K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	537	$31K
86901		<1%	9,094	$31K
87808		<1%	2,218	$31K
86355		<1%	913	$31K
82272		<1%	1,234	$31K
85014		<1%	4,124	$30K
94621		<1%	379	$30K
92602		<1%	153	$29K
72100		<1%	2,262	$29K
80179		<1%	2,005	$29K
87340		<1%	2,572	$29K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	24,524	$29K
J7030	Infusion, normal saline solution , 1000 cc	<1%	29,891	$29K
83525		<1%	2,309	$29K
94770		<1%	172	$29K
87806		<1%	1,159	$29K
86039		<1%	2,522	$29K
84146		<1%	1,226	$29K
D1208	Topical application of fluoride, excluding varnish	<1%	736	$28K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	42,420	$28K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	108	$28K
70491		<1%	162	$28K
73660		<1%	1,615	$27K
96113		<1%	1,113	$27K
70250		<1%	990	$27K
86665		<1%	1,594	$27K
85378		<1%	2,286	$27K
72040		<1%	2,945	$27K
88184		<1%	2,041	$26K
99001		<1%	982	$26K
71555		<1%	145	$26K
73000		<1%	2,455	$26K
92551		<1%	253	$26K
87581		<1%	647	$26K
0002A		<1%	818	$26K
86704		<1%	1,685	$25K
80184		<1%	295	$25K
84132		<1%	3,769	$25K
86225		<1%	1,698	$25K
69200		<1%	1,232	$25K
96131		<1%	234	$25K
J3590	Unclassified biologics	<1%	652	$24K
85384		<1%	2,328	$24K
73060		<1%	2,437	$24K
90734		<1%	772	$24K
90651		<1%	564	$23K
J2704	Injection, propofol, 10 mg	<1%	40,395	$23K
85250		<1%	951	$23K
73100		<1%	7,258	$23K
86800		<1%	1,445	$23K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	856	$22K
76819	Fetal biophysical profile; without non-stress testing	<1%	1,002	$22K
87046		<1%	1,259	$22K
84520		<1%	4,835	$22K
85660		<1%	2,853	$21K
87206		<1%	3,534	$21K
93017		<1%	247	$21K
42821		<1%	26	$20K
71250		<1%	266	$20K
93886		<1%	150	$20K
87493		<1%	486	$20K
71045	Radiologic examination, chest; single view	<1%	4,344	$20K
92522		<1%	641	$20K
87209		<1%	802	$20K
77073		<1%	2,729	$20K
49580		<1%	25	$19K
99195		<1%	1,946	$19K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	27,252	$18K
J0588	Injection, incobotulinumtoxin a, 1 unit	<1%	87	$18K
64999		<1%	114	$18K
76010		<1%	1,352	$18K
96409		<1%	2,567	$18K
90837	Psychotherapy session, about an hour	<1%	194	$18K
87632		<1%	87	$18K
92604		<1%	246	$18K
73030		<1%	2,382	$18K
84478		<1%	2,417	$18K
72070		<1%	1,650	$17K
87103		<1%	700	$17K
90715		<1%	1,598	$17K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	23,245	$17K
88307		<1%	922	$17K
76827		<1%	1,226	$17K
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	13,609	$17K
73564		<1%	2,198	$17K
90670		<1%	579	$16K
87107		<1%	329	$16K
J3490	Unclassified drugs	<1%	15,558	$16K
86359		<1%	591	$16K
86308		<1%	902	$16K
99155		<1%	6,194	$16K
17250		<1%	139	$16K
82610		<1%	819	$15K
88304		<1%	2,481	$15K
86235		<1%	386	$15K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	94	$15K
54640		<1%	12	$15K
84156		<1%	3,244	$15K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	569	$14K
87177		<1%	803	$14K
73502		<1%	575	$14K
82805		<1%	234	$14K
80175		<1%	192	$14K
96159		<1%	2,130	$14K
25565		<1%	80	$13K
29130		<1%	190	$13K
87272		<1%	1,058	$13K
80183		<1%	349	$13K
82140		<1%	556	$13K
87338		<1%	487	$13K
86664		<1%	762	$13K
D7111		<1%	27	$13K
D0230	Intraoral - periapical each additional radiographic image	<1%	2,044	$13K
36415	Collection of venous blood by venipuncture	<1%	104,484	$13K
86769		<1%	336	$13K
95713		<1%	177	$13K
85018		<1%	2,226	$13K
84202		<1%	713	$12K
92134		<1%	306	$12K
86618		<1%	540	$12K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	8,383	$12K
97802		<1%	2,007	$12K
84590		<1%	998	$12K
84446		<1%	915	$11K
97167		<1%	213	$11K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	2,693	$11K
77075		<1%	271	$11K
51784		<1%	103	$11K
87486		<1%	272	$11K
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	1,383	$11K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	12,180	$10K
86317		<1%	243	$10K
92609		<1%	182	$10K
92594		<1%	77	$10K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,220	$10K
70480		<1%	92	$10K
84480		<1%	652	$10K
82104		<1%	448	$9K
82390		<1%	721	$9K
86644		<1%	344	$8K
84550		<1%	1,640	$8K
69209		<1%	442	$8K
J3480	Injection, potassium chloride, per 2 meq	<1%	4,874	$8K
96150		<1%	124	$8K
87533		<1%	273	$8K
99153	Mod sedat endo service >5yrs	<1%	1,303	$8K
86341		<1%	312	$8K
86480		<1%	90	$8K
88271		<1%	373	$7K
82525		<1%	273	$7K
83605		<1%	526	$7K
87634		<1%	116	$7K
92650		<1%	455	$7K
86922		<1%	387	$7K
86357		<1%	225	$7K
99156		<1%	4,820	$7K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	12,548	$7K
92591		<1%	226	$7K
J0475	Injection, baclofen, 10 mg	<1%	26	$7K
62270		<1%	28	$6K
73592		<1%	621	$6K
81267		<1%	58	$6K
96368		<1%	43	$6K
96167		<1%	876	$6K
90648		<1%	544	$6K
90633		<1%	447	$6K
11100		<1%	25	$6K
92018		<1%	15	$6K
84630		<1%	585	$6K
12002		<1%	63	$6K
74220		<1%	153	$6K
82746		<1%	375	$6K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	3,984	$6K
82379		<1%	299	$6K
87498		<1%	130	$5K
93975		<1%	64	$5K
86880		<1%	728	$5K
93786		<1%	159	$5K
41010		<1%	16	$5K
82542		<1%	102	$5K
88342		<1%	1,733	$5K
11901		<1%	54	$5K
80201		<1%	189	$5K
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	25,261	$5K
97164		<1%	96	$5K
72197		<1%	32	$5K
84703		<1%	220	$5K
92250		<1%	1,140	$5K
80158		<1%	65	$5K
29505		<1%	105	$5K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	172	$5K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	3,483	$4K
V5264	Ear mold/insert, not disposable, any type	<1%	3,678	$4K
93242		<1%	55	$4K
76642		<1%	56	$4K
36591		<1%	394	$4K
J0690	Injection, cefazolin sodium, 500 mg	<1%	6,284	$4K
83921		<1%	159	$4K
90620		<1%	84	$4K
P9035	Platelets, pheresis, leukocytes reduced, each unit	<1%	18	$4K
84436		<1%	57	$4K
85245		<1%	103	$4K
99151		<1%	764	$4K
83789		<1%	156	$4K
51728		<1%	31	$3K
D0210	Intraoral - complete series of radiographic images	<1%	47	$3K
86015		<1%	333	$3K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,842	$3K
30300		<1%	100	$3K
36416		<1%	6,471	$3K
J9070	Cyclophosphamide, 100 mg	<1%	18	$3K
76506		<1%	32	$3K
83918		<1%	68	$3K
12032		<1%	31	$3K
74181		<1%	15	$3K
84075		<1%	389	$3K
88313		<1%	2,257	$3K
11104		<1%	15	$3K
86684		<1%	214	$3K
29515		<1%	269	$3K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,904	$3K
42975		<1%	130	$3K
0296T		<1%	23	$3K
J8540	Dexamethasone, oral, 0.25 mg	<1%	18,332	$3K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,209	$3K
82652		<1%	38	$2K
87536		<1%	33	$2K
90700		<1%	193	$2K
85347		<1%	316	$2K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	11,783	$2K
81243		<1%	15	$2K
85247		<1%	71	$2K
99188		<1%	3,375	$2K
J7070	Infusion, d5w, 1000 cc	<1%	1,040	$2K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,578	$2K
94617		<1%	13	$2K
92508	Group treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	107	$2K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,403	$2K
82747		<1%	97	$2K
92583		<1%	779	$2K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	64	$2K
85670		<1%	2,863	$2K
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,803	$2K
95250		<1%	129	$2K
82157		<1%	31	$2K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	1,063	$2K
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	10,300	$2K
86645		<1%	223	$2K
95076		<1%	14	$2K
J9370	Vincristine sulfate, 1 mg	<1%	2,729	$2K
D0270		<1%	85	$2K
0071A		<1%	75	$2K
C1769	Guide wire	<1%	2,822	$2K
80050	General health panel	<1%	556	$2K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,076	$2K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,984	$2K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	50	$2K
93243		<1%	55	$2K
86787		<1%	120	$2K
51798		<1%	250	$2K
82085		<1%	51	$2K
86337		<1%	86	$2K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	1,320	$1K
90723		<1%	329	$1K
94726		<1%	350	$1K
71275	Computed tomographic angiography, chest, with contrast material	<1%	12	$1K
84030		<1%	100	$1K
92590		<1%	15	$1K
0072A		<1%	52	$1K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,885	$1K
11981		<1%	15	$1K
73620		<1%	174	$1K
81000		<1%	66	$1K
82024		<1%	29	$1K
87075		<1%	150	$1K
82465		<1%	53	$1K
J1756	Injection, iron sucrose, 1 mg	<1%	254	$1K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	742	$1K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	1,128	$1K
J1815	Injection, insulin, per 5 units	<1%	259	$997.54
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	8,046	$987.78
85732		<1%	103	$966.68
D0340		<1%	36	$951.94
91200		<1%	795	$917.34
86008		<1%	26	$895.37
V5241	Dispensing fee, monaural hearing aid, any type	<1%	37	$851.12
76604		<1%	12	$813.35
86774		<1%	29	$794.39
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	6,186	$772.05
86709		<1%	54	$750.20
93971		<1%	26	$744.90
84481		<1%	26	$717.33
88280		<1%	26	$701.62
97168		<1%	14	$694.90
51797		<1%	13	$681.39
94761		<1%	1,343	$680.16
85280		<1%	27	$678.04
82261		<1%	41	$655.27
88291		<1%	43	$650.75
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	9,204	$645.88
76937		<1%	14	$641.49
90685		<1%	58	$637.95
87522	Neg quan hep c or qual rna	<1%	13	$626.10
97804		<1%	131	$624.76
88312		<1%	601	$608.53
C9290	Injection, bupivacaine liposome, 1 mg	<1%	110	$570.81
73092		<1%	30	$566.33
86258		<1%	90	$538.15
73700		<1%	13	$533.00
82775		<1%	27	$527.99
98960		<1%	60	$525.81
D0470		<1%	19	$524.81
83930		<1%	27	$455.22
83090		<1%	13	$436.90
95012		<1%	462	$428.94
76857		<1%	25	$428.89
95199		<1%	133	$426.92
96411		<1%	314	$418.94
83020		<1%	27	$418.49
92511		<1%	15	$408.83
J7510	Prednisolone oral, per 5 mg	<1%	2,111	$361.21
98961		<1%	17	$351.42
84445		<1%	13	$339.72
0124A		<1%	16	$322.27
90677		<1%	109	$316.56
36592		<1%	34	$302.38
84510		<1%	27	$296.06
0297T		<1%	23	$294.40
87184		<1%	44	$291.31
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	463	$277.32
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	358	$265.57
J9260	Injection, methotrexate sodium, 50 mg	<1%	1,607	$263.29
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	6,969	$262.13
82945		<1%	64	$259.39
84210		<1%	13	$253.38
90732		<1%	28	$253.16
84157		<1%	64	$245.97
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	346	$237.55
73600		<1%	104	$226.05
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	<1%	633	$208.23
J1940	Injection, furosemide, up to 20 mg	<1%	93	$205.08
82438		<1%	26	$204.79
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	275	$198.51
92133		<1%	156	$192.55
85270		<1%	13	$191.86
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	1,047	$184.62
94760		<1%	272	$174.35
91300		<1%	2,116	$155.32
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	934	$154.81
86765		<1%	14	$146.41
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	241	$141.67
J0706	Injection, caffeine citrate, 5 mg	<1%	197	$140.08
90710		<1%	56	$138.97
89230		<1%	13	$127.18
86060		<1%	15	$117.18
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	<1%	292	$115.72
J7699	Noc drugs, inhalation solution administered through dme	<1%	1,477	$111.49
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	209	$109.43
D0350		<1%	42	$99.63
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	100	$98.83
94664		<1%	171	$90.61
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	131	$84.08
90472	Immunization administration, each additional vaccine (list separately)	<1%	35	$83.32
90674		<1%	13	$80.60
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	91	$78.82
86431		<1%	13	$71.98
73120		<1%	24	$66.60
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	671	$60.96
99152		<1%	162	$39.30
J1644	Injection, heparin sodium, per 1000 units	<1%	519	$33.90
88341		<1%	19	$28.51
70260		<1%	12	$21.17
36593		<1%	13	$20.52
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	145	$12.57
73080		0%	28	$0.00
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	0%	56	$0.00
94690		0%	26	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	16	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	147	$0.00
V5261	Hearing aid, digital, binaural, bte	0%	44	$0.00
J0290	Injection, ampicillin sodium, 500 mg	0%	79	$0.00
95018		0%	14	$0.00
J0736	Injection, clindamycin phosphate, 300 mg	0%	47	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	42	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	28	$0.00
J2300	Injection, nalbuphine hydrochloride, per 10 mg	0%	12	$0.00
V5257	Hearing aid, digital, monaural, bte	0%	13	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	12	$0.00
96168		0%	329	$0.00
91307		0%	143	$0.00
V5160	Dispensing fee, binaural	0%	60	$0.00
J7609	Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg	0%	2,920	$0.00
D9997		0%	441	$0.00
C9399	Unclassified drugs or biologicals	0%	46	$0.00
J2060	Injection, lorazepam, 2 mg	0%	123	$0.00
J7050	Infusion, normal saline solution, 250 cc	0%	313	$0.00
Q0164	Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	17	$0.00
88311		0%	16	$0.00
J3410	Injection, hydroxyzine hcl, up to 25 mg	0%	21	$0.00
D9248		0%	37	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	19	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRICCA, MONICA (VP REVENUE CYCLE)

Same official

Other billing entities under RICCA, MONICA

Full network →

Provider	Location	Paid
Childrens Hospital of Wisconsin, INC.	Milwaukee, WI	$18.98M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.